Medicis Hits Ranbaxy With Acne Drug Patent Suit
In its ongoing bid to protect Solodyn from generic competitors, skin health specialist Medicis Pharmaceutical Corp. has accused Indian generics maker Ranbaxy Laboratories Ltd. of infringing a patent for the popular...To view the full article, register now.
Already a subscriber? Click here to view full article